Jessica Nye, PhD

In a placebo-controlled portion of a clinical trial, researchers sought to describe the effect of eptinezumab on self-reported work productivity.

This study sought to investigate the risk of death after hospitalization for 28 physical comorbid conditions in people who had been hospitalized for substance use disorder.

A team of investigators created and implemented a guideline that standardized opioid prescribing in accordance with recommendations from the Centers for Disease Control and Prevention.

Investigators sought to identify adjuvant therapy for intrathecal bupivacaine that would be effective for pain control among women undergoing cesarean delivery.

Investigators assessed the impact of botulinum toxin A injections on hyperactivity of pelvic floor musculature among women with provoked vestibulodynia.

Investigators conducted a prospective observational study to assess the impact of wearable health technologies on pain management and quality of life among individuals with chronic pain.

Compared with propofol-alfentanil, remimazolam-alfentanil produced fewer adverse effects and led to a better recovery process after a surgical procedure.

Investigators assessed the impact of an online pain management program on symptoms of anxiety and depression among patients with chronic pain.

A team of investigators assessed the safety and efficacy of palmitoylethanolamide, a biologically active lipid mediator and an endogenous ligand of the endocannabinoid system, in managing pain associated with diabetic peripheral neuropathy.

In a post hoc analysis, researchers determined whether erenumab for migraine had a wearing-off effect throughout a monthly treatment cycle.